President Donald Trump at a meeting of the Coronavirus Task Force and pharmaceutical executives, March 2, 2020 (Kevin Dietsch/Sipa via AP Images)
As the curtain closes on the Trump presidency, biotech wrestles with its future in a divided America
At 11 am after the election, Sherlock Biosciences CEO Rahul Dhanda snuck into his office and, in the couple minutes between meetings, fired off an …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
